Evidence map›Paper›PMID 28715391›Full record

ArticleJournal of visualized experiments : JoVE2017

Isolation of Primary Murine Retinal Ganglion Cells (RGCs) by Flow Cytometry.

Sumana R Chintalapudi, Need N Patel, Zachary K Goldsmith, Levon Djenderedjian, Xiang Di Wang, Tony N Marion, Monica M Jablonski, Vanessa M Morales-Tirado

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. A complete spatial map of mouse retinal ganglion cells reveals density and gene expression specializations.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sumana R ChintalapudiDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center.
Need N PatelDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center.
Zachary K GoldsmithDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center.
Levon DjenderedjianDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center.
Xiang Di WangDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center.
Tony N MarionDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center.
Monica M JablonskiDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center; Department of Anatomy and Neurobiology, University of Tennessee Health Science Center; Department of Pharmaceutical Sciences, University of Tennessee Health Science Center.
Vanessa M Morales-TiradoDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center; Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center; vmorale1@uthsc.edu.
University of Tennessee Health Science Center · US

Funding

Genetic Modulators of GlaucomaR01EY021200 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JABLONSKI, MONICA M · 2011 to 2022
$3.2M
NEI NIH HHS R01 EY021200
6 · The paper itself

Abstract

Neurodegenerative diseases often have a devastating impact on those affected. Retinal ganglion cell (RGC) loss is implicated in an array of diseases, including diabetic retinopathy and glaucoma, in addition to normal aging. Despite their importance, RGCs have been extremely difficult to study until now due in part to the fact that they comprise only a small percentage of the wide variety of cells in the retina. In addition, current isolation methods use intracellular markers to identify RGCs, which produce non-viable cells. These techniques also involve lengthy isolation protocols, so there is a lack of practical, standardized, and dependable methods to obtain and isolate RGCs. This work describes an efficient, comprehensive, and reliable method to isolate primary RGCs from mice retinae using a protocol based on both positive and negative selection criteria. The presented methods allow for the future study of RGCs, with the goal of better understanding the major decline in visual acuity that results from the loss of functional RGCs in neurodegenerative diseases.

Indexed as

AnimalsFlow CytometryMiceRetinaRetinal Ganglion Cells

Identifiers

PMID28715391
PMCPMC5608546
OpenAlexW2724708448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.